Mereo BioPharma Group plc - SPON ADS (MREO)

Historical Portfolio Holders from Q2 2019 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / SPON ADS
Shares, excl. options Q2 2024
101M
Holdings value Q2 2024
$362M
Value change Q2 2024
+$59.9M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
75
Number of buys Q2 2024
33
Number of sells Q2 2024
-41
Average buys Q2 2024 %
+0.001%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 101M $362M +$59.9M $3.60 75
2024 Q1 84M $277M +$15.2M $3.30 77
2023 Q4 78.5M $181M +$12.8M $2.31 59
2023 Q3 69.9M $90.2M +$9.9M $1.29 52
2023 Q2 63.6M $84M +$2.51M $1.32 48
2023 Q1 60.8M $43M -$705K $0.71 56
2022 Q4 61.4M $46.1M -$7.73M $0.75 56
2022 Q3 68M $58.5M -$7.13M $0.86 56
2022 Q2 73.6M $82.5M -$16.9M $1.12 58
2022 Q1 88.9M $99.6M -$3.07M $1.12 55
2021 Q4 90.9M $145M -$12.2M $1.60 67
2021 Q3 87.5M $212M -$26.6M $2.42 57
2021 Q2 89.6M $284M -$2.19M $3.17 68
2021 Q1 90.2M $304M +$111M $3.37 65
2020 Q4 57.1M $205M +$140M $3.58 42
2020 Q3 14.3M $37.4M +$18M $2.62 20
2020 Q2 7.27M $22.3M +$12.8M $3.06 18
2020 Q1 1.4K $1K -$469K $0.71 1
2019 Q4 1.23M $4.05M -$2.32M $3.28 8
2019 Q3 1.76M $5.13M -$79.4K $2.94 12
2019 Q2 1.72M $4.19M +$4.19M $2.44 13